Thrombinoscope BV Revenue
Hospitals and Health Care • 
Netherlands • 1-10 Employees
$
Thrombinoscope BV revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Hospitals and Health Care industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Thrombinoscope BV
Peter Giesen
Owner
Company overview
| Headquarters | Netherlands |
| Website | |
| NAICS | 62 |
| SIC | 873 |
| Employees | 1-10 |
About Thrombinoscope BV
Thrombinoscope BV is a diagnostic company that sells a test to measure blood coagulation. This test, the calibrated automated thrombogram (CAT), gives a good indication if a person is at risk for thrombosis or bleeding. It can be used to detect any pathology to the clotting system. It can monitor the treatment with antithrombotic drugs or it can be used to develop new pro- or antithrombotic drugs. The test is used for research only and is being developed to be used in the clinic.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Funding Data
Thrombinoscope BV has never raised funding before.
Denmark
Germany
Cyprus
United Kingdom
United States
CanadaFrequently asked questions
Thrombinoscope BV is located in NL.
Thrombinoscope BV generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.
Thrombinoscope BV has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Thrombinoscope BV has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
